Biohaven Pharmaceutical (BHVN) - Proyeksi bathi mangsa ngarep
The forward profitability trend demonstrates the potential of Biohaven Ltd. (BHVN), where the level captures the current state. This momentum is supported by aggressive expert hiring and an option-based incentive system. The strategy is based on diversifying development from epilepsy to migraine. Currently, Biohaven Ltd. (BHVN) is generating cash flow by relying on innovative research rather than ready-made commercial products.
Rincian analitis lan laporan data perusahaan Biohaven Ltd. (BHVN)
- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi pasar:
- indikator kapitalisasi buku:
- data utang lan likuiditas:
Total Utang marang Modal Biohaven Ltd.|BHVN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Biohaven Ltd.|BHVN - Utang perusahaan|Utang-utang marang kapitalisasi buku Biohaven|BHVN - Utang jangka dawa|Utang jangka cendhak perusahaan Biohaven|Indikator likuiditas cepet biohavenpharma.com
- data bathi resik lan rasio valuasi:
BHVN - Bathi pungkasan|Bathi sing dikarepake Biohaven Ltd.|BHVN - Rasio rega marang bathi|Prakiraan rega marang bathi Biohaven|BHVN - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Biohaven Corp|BHVN - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Biohaven|BHVN - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan biohavenpharma.com|BHVN - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Biohaven Ltd.
- data total pendapatan lan volume dodolan:
Ringkesan analisis perusahaan:Biohaven Corp, BHVN
For Biohaven Ltd., which develops unique platforms to combat pathological proteins in neurology, the net profit forecast reflects the market valuation of the commercial potential of its therapeutic breakthroughs. By analyzing the company's earnings forecast history, an investor can see consolidated institutional expectations, making it possible to compare the current share price with the fundamental consensus and avoid overpaying at the cycle peak.
Pesaing Biohaven Ltd.
BIIB (Biogen) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik NBIX (Neurocrine Biosciences, Inc.)|Proyeksi bathi mangsa ngarep RGC|Axsome Corp - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep ACAD (ACADIA Corp)|XENE: Prakiraan bathi resik|Viking Therapeutics Inc - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Bathi sing dikarepake|DNLI (Denali Therapeutics Inc) - Bathi sing dikarepake|Bathi sing dikarepake Harmony Biosciences Holdings, Inc.|Prakiraan bathi resik AMLX (Amylyx Pharmaceuticals, Inc.)|Bathi mangsa ngarep TRVI (Trevi Therapeutics)|PRAX (Praxis Precision Medicines Inc) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Anavex Corp AVXL|CeriBell, Inc. - Bathi sing dikarepake|PRTA: Bathi mangsa ngarep|Prakiraan bathi perusahaan Alector ALEC|Annexon Inc. (ANNX) - Bathi sing dikarepake|Omeros Corp. - Penghasilan resik sing dikarepake|NGNE (Neurogene Therapeutics) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep AC Immune Corp (ACIU)|Bathi sing dikarepake Voyager Therapeutics (VYGR)|NMRA (Neumora Therapeutics) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Scilex Holding Co. SCLX|Penghasilan resik sing dikarepake TVGN|ACOG - Bathi sing dikarepake|Penghasilan resik sing dikarepake CGTX (Cognition Therapeutics, Inc.)|IKT: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake cassavasciences.com (SAVA)|ASRT (Assertio Holdings, Inc.) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep coyatherapeutics.com (COYA)|Bathi mangsa ngarep VTGN (vistagen.com)|Prakiraan bathi perusahaan Ovid Rx|Proyeksi bathi mangsa ngarep ABOS (acumenpharm.com)|CRVO: Prakiraan bathi resik|Alterity Therapeutics Ltd. - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake clene.com|pepgen.com (PEPG) - Bathi sing dikarepake|Bathi resik sing dikarepake Jupiter Neurosciences, Inc. (JUNS)|Bathi sing dikarepake Relmada Therapeutics|Prakiraan bathi resik ANVS (Annovis Bio, Inc.)|Proyeksi bathi mangsa ngarep GRCE|Prakiraan bathi perusahaan Firefly Neuroscience, Inc.|Bathi sing dikarepake anewmeds.com KLTO|Prakiraan bathi perusahaan NeuroSense Therapeutics (NRSN)|RVPH: Bathi mangsa ngarep|MTVA - Proyeksi bathi mangsa ngarep|NRXS (neuraxis.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake Helius Medical Technologies Inc. (HSDT)|Bathi sing dikarepake Passage Bio Corp|Bathi mangsa ngarep Neuphoria Therapeutics (NEUP)|Proyeksi bathi mangsa ngarep NERV|ATHA - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ADXN (addextherapeutics.com)|Alzamend (ALZN) - Bathi resik sing dikarepake|CYCN: Bathi mangsa ngarep|Bathi resik sing dikarepake Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Bathi sing dikarepake|Bathi resik sing dikarepake Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Proyeksi bathi mangsa ngarep|BCLI (Brainstorm Cell Therapeutics Inc.) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep CARA|CHRO - Bathi resik sing dikarepake|Eliem Therapeutics - Bathi mangsa ngarep|Intra-Cellular (ITCI) - Bathi resik sing dikarepake|LBPH - Bathi sing dikarepake|MRNS - Proyeksi bathi mangsa ngarep|NKGN: Proyeksi bathi mangsa ngarep|NeuroBo Pharma (NRBO) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep SAGE|Prakiraan bathi resik SNPX (Synaptogenix, Inc.)|Bathi sing dikarepake Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Anew Medical WENA|Bathi resik mangsa ngarep CERE (Cerevel)
